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Abstract—Global medical tourism service (GMTS) supply 
chain is fast gaining momentum, and relationships between its 
participants, including patients, are increasingly becoming 
complex and subject to dynamic change. Medical tourism 
service in developing countries has emerged as a niche segment 
of the tourism industry, despite the global economic downturn. 
The GMTS supply chain is driven by an increasing 
accessibility of quality healthcare services, and low healthcare 
costs in developing countries. Many factors such as low cost, 
government’s role, and private investments have contributed 
to a significant growth in the medical tourism service market 
in countries such as, Thailand, India, Singapore, Malaysia, 
Poland, Austria and Saudi Arabia. This article is motivated by 
the lack of available supply of cost effective, timely and private 
medical services in developed economies and the need to 
understand the predictable nature of demand drivers of 
medical tourism to developing countries. We then, consider 
conceptualizing cost, waiting time and privacy as important 
characteristics upstream and downstream the global medical 
supply chain links. The authors of this article consider that as 
medical tourism product is similar to a consumer product in 
supply chain management, to a certain extent, many of the 
operations objectives found in a manufacturing supply chain 
can also be readily applicable to the medical tourism supply 
chain.  We propose and test a model that is founded on three 
supply chain related constructs—cost, waiting time and 
privacy to inform the demand and also to ensure the smooth 
flow between the supply chain links for global medical service.    
 
Keywords-supply-chain; medical services; cost; waiting period; 
privacy, regression analysis. 
 
I. INTRODUCTION 
Medical tourism, where patients travel for alternative 
therapies, diagnostic treatment, and complex invasive 
elective and cosmetic surgeries has grown rapidly in the past 
decade. USA and Europe were the industrial, business and 
healthcare centers of the world from 1900 to 1997 Asian 
crisis. The affluent and rich from Asia and the Middle East 
travelled to these countries in order to receive advanced 
specialised medical treatment and services. This trend has 
now reversed since the 1997 Asian financial crisis.  
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Medical tourism has been widely acknowledged by 
academic scholars in this twenty first century [1]–[8].  Like 
product supply chain, a GMTS supply chain can be 
considered the network of entities that plan, source, fund, 
and distribute medical services and manage associated 
information and finances from manufacturers to medical 
service delivery points. Factors such as cost, speed (waiting 
period) and reliability (privacy) are of utmost importance in 
this kind of supply chain. There are numerous actors and 
types of relationships involved in making GMTS supply 
chain work: patients, donors and funders, government 
policymakers, procurement agents, program managers, 
regulators, suppliers, distributors, and dispensing staff from 
the public and private hospitals. Developing economies such 
as Thailand since 1997 and India since 2003, have been 
promoting their respective countries as a first world Joint 
Commission International (JCI) accredited, state-of-the-art 
medical technology, affordable low cost, no waiting period, 
health and medical tourism-destinations to the world [9]. 
 
The main purpose of this study is to examine through a 
theoretical model (Figure 1) the predictive relationships 
between three key GMTS supply chain factors - cost, no 
waiting period (speed) and privacy (reliability), and the 
decision to travel to another country for medical treatment. 
These empirical findings will contribute to this field of the 
medical tourism service supply chain because the 
relationship between the proposed key factors and the 
decision to demand medical tourism has not been previously 
tested. This empirical study will thus support the literature 
that members of the GMTS supply chain such as medical 
tourists are making informed personal healthcare decisions 
to get the best outcome at an affordable price, with low cost, 
no waiting period and privacy in treatment.  
 
 
II. LITERATURE REVIEW 
A. Global medical tourism economic outlook  
 
Global growth of the supply chain medical tourism 
phenomenon is based on two key factors (a) the number of 
foreign medical tourists travelling (b) the amount of revenue DOI: 10.5176/2010-4804_2.2.204
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they generate in terms of foreign exchange [2], [10]. 
However, it is also important to ensure the smooth flow 
between the global medical tourism supply chain links such 
as: (a) marketing, (b) travel arrangement (c) diagnostic (pre-
surgery) and medical treatment/surgery (d) post-surgery 
care and recovery care (e) tourism activities (f) departure 
and follow-up in the home country (See Appendix 1). 
According to [11] at the international level, the health and 
medical tourism industry is sustained by 617 million 
individuals with an annual growth rate of 3.9% annually and 
worth US$513 million. Various studies have reported that 
the global medical tourism industry was worth US$20 
billion in 2005 [12] and generates US$60 billion in business 
globally [13]. The economic impact of medical tourism 
globally and in the developing countries in particular is 
significant [2]. For instance According to RNCOS report 
[12], the total foreign exchange earned through international 
medical tourism in 2005 by Thailand was US$ 915 million 
from 100,0000 medical tourists, Singapore US$ 915 million 
from 350,000 medical tourists, Malaysia US$ 40 million 
from 400,000 medical tourists, and India US$ 333 million 
from 180,000 medical tourists [12, pp.13-14]. Further, a 
total of nearly 1.9 million medical tourists visited Asia in 
2005. Medical Tourism is expected to be worth US$ 4.4 
billion [14] and globally it is worth US$ 60 billion annually 
[13] and the market is predicted to grow to $2 billion by 
2012 [15].  
 
B.  State of the Art 
Bookman and Bookman [2] together with Heung, 
Kucukusta and Song [8], have mentioned the supply and the 
demand side factors, where a person travels away from 
home for medical treatment along with the intention of 
having a leisurely vacation. Smith and Forgione [16] have 
identified the factors influencing the patient’s choice of 
specific country (economic, political and regulatory) and 
that choice of international medical facility is impacted by 
costs, quality of care, physicians training and accreditation 
in their two-stage model. This model does not determine the 
demand and supply side factors together with advertising, 
and other factors affecting the medical tourism industry as a 
whole.  Authors such as Sinha and Kohnke [17]  have based 
their healthcare supply chain model on the widening gap 
between the growing demand and supply of high-quality, 
cost-effective, and timely health care, problem faced by all 
developed and developing countries. They have developed a 
framework based on the three constructs affordability, 
access and awareness to understand the demand and inform 
the supply chain with a macro-centric view of the health 
care sector, in order to link the development with the 
delivery of care based on the interdependence between key 
industries of the health care supply chain. The different 
models dealing with medical care suggests that in the 
twenty-first century global medical tourists, primarily from 
developed countries, are travelling to developing countries 
for medical care, that is not only non-invasive in nature but 
also invasive using latest technology and surgical 
procedures at very affordable costs.  
Cost  
Global service supply chain companies need to understand 
both the cost of providing services to their customers and 
what their customers are willing to pay for the level of 
service they need. Understanding cost is crucial if 
competitive service supply chains are to charge their 
customers the right price for delivering services like 
medical. Most of the developed countries’ medical tourists 
select a developing country for treatment due to their first 
world health infrastructure, advantage of English language, 
availability of alternative therapies like Ayurvedic spas and 
treatment, low cost and no waiting period [2], [8], [9]. This 
is a critical supply chain costing strategy as it prompts 
members of the supply chain to compare two or more 
alternative supply chains in a geographical area to determine 
which one gives defined service levels for the lowest cost. 
As can be seen from table 1, medical tourists essentially 
compare costs to those in comparable countries for similar 
service commodities.  
 
TABLE I.  COST COMPARISON FOR SELECTED SURGERIES 









Australia $33,340 $23,800 $20,089 $7,113 
USA (US$) $130,000 $43,000 $40,000 $20,000 
India 
(US$) 
$9,300 $7,100 $8,500 $6,000 
Thailand 
(US$) 
$11,000 $12,000 $10,000 $4,500 
Singapore  $16,500 $9,200 $11,100 $6,000 
Korea 
(US$) 
$34,150 $11,400 $24,100 $12,700 
 
Source: [32] American Medical Association (2008) and Medi-bank Private 
(figures from 2006 / 2007 financial year prices)  
 
For example, as seen from table-1, in Australia, a heart 
bypass surgery can cost up to Aus $ 33,340, which is 
covered by private health insurance when the surgery is 
undergone in Australian hospitals. Private health funds do 
not cover overseas medical cost. While in India's best 
hospitals it could cost between $9,000 and $10,000. A heart-
valve replacement costing US$200,000 or more in America 
can go for US$10,000 in India including return airfares and 
a holiday package [32]. In many cases, these cheaper 
packaged prices include the whole tourism supply chain: 
airfares, accommodation and even sightseeing and tour 
services to and from airport, taking care of everything from 
the time of arrival to departure. According to Thakkar [33], 
many Americans are traveling abroad for medical treatment 
as they are either under insured or have no medical health 
insurance cover, besides many expatriates from Malaysia, 
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India are also having medical treatment in their country of 
birth besides meeting family members. Given the cost 
comparisons of medical surgery between countries as well 
as the more increasingly available information regarding 
accreditation of medical facilities, it is becoming easy and 
affordable for patients from developed countries such as 
USA, to judge and compare the standards of medical care 
and cost, and make decisions about travelling abroad to 
Thailand, India or Mexico for medical treatment, as seen in 
table 3 [33], where a bypass surgery cost US $8500 in India 
compared to US $144,000 in USA and hip-replacement cost 
US $50,000 in USA compared to US $8000 in India and 
US$ 14,000 in Thailand. Thus in 2007, nearly 750,000 
Americans travelled abroad for elective medical treatment 
which was affordable, at low cost and quicker medical 
treatment with no waiting period. 
 
Hypothesis 1: Low medical treatment cost will influence the 
demand for medical tourism. 
Waiting Time 
Value, in the context of health service supply chain, can be 
defined as something that the customer is willing to pay for. 
Value-adding activities transform materials and information 
into something a customer wants. Non-value-adding 
activities consume resources and do not directly contribute 
to the end result desired by the customer. Long waiting 
periods, therefore, is defined as anything that does not add 
value from the customer's perspective. Waiting time from 
point of referral to actual treatment for elective surgery and 
other complex surgeries in developed country is an 
important issue [18]. According to OECD report by Hurst & 
Siciliani [19], waiting time for elective surgery may vary 
from country to country in terms of the definition of waiting 
period and aggregation method. For their study they have 
defined waiting time in two ways. (1) “waiting time 
between specialist assessment and (2) the time the patient is 
admitted for surgery” (‘inpatient’ waiting time). A study by 
Carroll, et al. [20], found that the longest waiting times for 
all four procedures were reported in the United Kingdom, 
Sweden and Canada, with some waiting times for elective 
procedures > 9 months. Another study by Seddon and 
French et al. [21] also found that waiting time for coronary 
artery bypass surgery was longer in New Zealand then in 
Ontario Canada due to funding constraints. 
 
Hypothesis 2: No waiting period for an elective medical 




The members of the medical service supply chain need to 
develop trust in order to use services over the time. Trust is 
a critical element that enables medical service supply chain 
to keep the confidentiality of what medical tourist consider 
private information. There are many dimensions to the 
notion of “privacy” convenience of medical treatment 
confidentiality of medical record, condition and treatment to 
avoid embarrassment, and control of personal health 
Information. Larry [22] puts emphasis on guarding patient 
privacy and confidentiality of information in the age of 
information systems. Privacy involves many issues such as 
desire for privacy of private information regarding travel 
abroad for medical treatment, type of medical treatment, 
individual health information [13], [23]-[25].  
 
According to Little [26], there are three key reasons why 
privacy is important. a) The patient has control over 
diagnostic test results, procedures and treatments done 
abroad, at his or hers own expense. b) Part of a “boutique” 
medical experience is recuperating – away from home 
business where the medical patient has complete anonymity. 
c) Finally, women may be prone to discuss about their 
cosmetic surgeries, however, men are more inclined to value 
their privacy about medical/cosmetic procedures done 
abroad while on a vacation or a business trip.  
 
Privacy of medical treatment in terms of security and 
confidentiality is very important for medical tourists coming 
from Arab and East European countries to Germany for high 
quality medical treatment, combining it with a holiday with 
family in a beautiful natural location [27]. “The most 
popular treatments requested by Arab patients are plastic 
surgery, physical therapy and treatment of heart disease, 
infertility and orthopaedic problems. While the patients of 
cosmetic medicine are looking primarily for privacy and 
high quality in small private clinics and medical resorts, the 
cardiology and gynecology patients are mainly to be found 
in the huge medical enters attached to medical faculties and 
colleges in big cities” [27, p.22]. Third hypothesis is related 
to privacy of treatment abroad in terms of pre and post 
operative offshore care followed by a vacation if the 
surgeon permits people to travel for medical treatment due 
to privacy 
 
Hypothesis 3: Privacy of medical treatment will increase the 




Figure 1. Factors impacting on the GMTS supply chain 
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III.  RESEARCH METHODS 
The hypothesized model (Figure 1) was tested using 
multiple regression analysis. Multiple regression analysis 
was used to analyse if there is a predictive relationship 
between one independent variable and a criterion, dependent 
variable [28]. Stepwise multiple regressions were performed 
to predict the relative contribution of cost, waiting time and 
privacy on the dependent variable decision to travel 
overseas to undertake medical treatment. Hair et al. [29] 
stated that multiple regression analysis provides a means of 
objectively assessing the magnitude and direction of each 
predictor’s relationship to its dependent variable.  
The study was designed to quantitatively test three key 
hypotheses (cost, waiting time and privacy) and therefore 
data were collected using self-administered online surveys. 
The survey was administered via telephone to a general 
population of potential regional Australia citizens. The 
interviewing was conducted over a period of 4 weeks in 
2010. Interviews were conducted between the hours of 
10:30 am to 2:30 pm and 4:30 pm to 8:30 pm, Monday 
through to Friday and between the hours of 11:30 am and 
4:00 pm on Saturday and Sunday. If the interviewers were 
unsuccessful in establishing contact on their first call, a 
minimum of five call-back attempts was made. Upon 
making contact, interviewers identified themselves and then 
asked the screening questions for selecting the respondent. 
The average interview length was 29 minutes. 
The total research sample (N=1273) consisted of 
respondents represented by Australia-born (88.7 %) and 
Non-Australian (11.3 %), reasonably well educated (44.5 % 
post-secondary, 55.5 % high school/vocational education). 
About 62.5 % were employed, almost 30 % were 
pensioners, approximately 41.8 % of the respondents have 
an annual income of more than $ 52,000, and about 69.7 of 
the participants were married.  
The surveys assessed relationships between different factors 
influencing the decision to travel abroad for medical 
treatment. The scales used for this study’s variables were 
adapted for this study. Some items in the privacy scale 
measured perception of convenience, anonymity, and 
confidentiality of medical procedures and services. The final 
survey comprised Likert-scale items, and nine demographic 
items. The Cronbach’s Alpha for the cost scale in the 
current study was 0.757, 0.86 for the waiting time scale, for 
0.962 for the privacy scale and 0.812 for the demand for 
medical tourism scale. 
IV.  FINDINGS 
Hypotheses one, two, and three put forward in the literature 
review were tested using stepwise models which were 
generated at the p<0.05 level. The results for each 
proposition are exhibited in Table 1 
Hypothesis 1: Low surgical cost and affordability will 
increase the demand for medical tourism. 
TABLE II.  REGRESSION ESTIMATE OF COST, WAITING TIME AND PRIVACY 
































The first hypothesis examines the direct influence that cost 
exerts on the demand for medical tourism and was 
supported by the findings. Linear regression results indicate 
strong support based on the value of ß (Table 1). As per 
Table 1, cost is a significant predictor of demand for 
medical tourism (p<.05). The results indicated that low 
surgical cost alone accounted for 25.2 percent of the 
variance (R square) in demand for medical tourism. A value 
of ß = .32, R2 =.25, F(3, 426) = 60.12 , p <.001 for the 
predictor cost means that there is a direct relationship 
between cost and demand for medical tourism such that the 
greater the importance placed on low surgical cost the 
higher the chances an individual will demand medical 
tourism. 
Hypothesis 2: No waiting period for an elective surgery, 
will significantly increase the demand for medical tourism. 
The second hypothesis examines the direct influence that no 
waiting period exerts on the demand for medical tourism 
and was supported by the findings. Linear regression results 
indicate strong support based on the value of ß (Table 1). As 
per Table 1, no waiting period is a significant predictor of 
demand for medical tourism (p<.05). The results indicated 
that no waiting period accounted for 28.6 percent of the 
variance (R square) in demand for medical tourism. A value 
of ß = .43, R2 =.24, F(3, 426) = 27.85 , p <.001 for the 
predictor no waiting means that there is a direct relationship 
between no waiting and demand for medical tourism such 
that the greater the importance placed on no waiting time 
the higher the chances an individual will demand medical 
tourism. 
Similarly, the positive coefficient associated with the 
privacy variable shows that the greater the importance 
placed on privacy the higher the chances an individual will 
make the decision to travel for medical treatment and 
demand medical tourism, (ß = .14), F(3, 426) = 9.61, 
p<.001. This supports hypothesis 3 which states: 
Hypothesis 3: Privacy of treatment will increase the demand 
for medical tourism. 
 
V. CONCLUSIONS  
This research provides insights into the importance of three 
key service supply chain factors (cost, waiting period and 
privacy) in the process of making a decision to travel abroad 
for medical treatment thus impacting on the GMTS supply 
chain. Therefore, in addressing hypothesis one, it is 
important to indicate that surgical cost comparisons between 
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the patient’s country of residency and overseas country is 
vital in terms of affordability of medical treatment and 
decision to undertake this type of treatments overseas. These 
findings are in line with much of the emerging literature that 
is based on the growth of medical tourism industry in 
developing countries [1], [2], [7], [6], [30], [31] - [33].  
This should prompt the government to continue introducing 
incentives such as expediting medical tourism visas, 
lowering import duties on medical equipments, increasing 
depreciation rates to allow the early replacement of old 
medical equipment and subsidies rates for prime lands to be 
developed for medical tourism purposes. Likewise, the 
government should bear in mind that although maximising 
profits is the key goal of any supply chain, the focus should 
be on implementing advanced medical technologies and 
expanding health programs for those who are unable to pay. 
 
The research, in addressing hypothesis two which suggest 
that no waiting period for an elective surgery, will 
significantly increase the demand for medical tourism, is 
consistent with the literature [3], [13], [18], [23], [24]. It is a 
challenge for medical system in Western countries to reduce 
the waiting time for seeing a specialist and elective surgery. 
Thus, Hurst & Siciliani [19], further note that according to 
Organisation of Economic Cooperation and development 
(OECD) waiting time is used for rationing given the 
shortage of skilled surgeons/specialists to restrict access to 
medical care in countries having public provision, that is 
government supply chain management of health care and 
universal health insurance these further results in pain and 
poor health for the patient in the long-run and may reduce 
longevity and quality of life. As longer the waiting time for 
elective surgery, from the time of being diagnosed, the 
patient may suffer with pain and the medical problem can 
get worse. For example tumour or the hip can get worse 
with deteriorating health and overall quality of life for the 
patient. Thus medical tourists are making decisions based 
not only on the cost and affordability of the treatment, but 
also shorter or no waiting time for surgery, to reduce their 
incidence of physical pain and get surgery on time to 
improve their health by travelling to another country.  
 
This is a clear message to developing nations such as India 
who should continue increasing the physician’s density per 
1,000,000 of population by implement policies to decrease 
the rate of migration of medical practitioners to more 
developed countries. Likewise government should work 
with JCI accredited hospitals to provide salary incentives to 
attract resident as well as non-resident Indian (NRI) 
nationals who are medically trained overseas. Further, 
private hospitals should provide for greater capacity of 
hospital beds to serve its domestic population to promote 
equitable access. This indicates that healthcare equity in the 
local populations of India or Thailand effectively copes with 
increasing flows of foreigners seeking medical treatment. It 
also may be an indication that these countries are not yet 
reaching capacity limits hence other countries cannot 
capitalize on its medical tourist overflows. 
Hypothesis three suggests that privacy of treatment will 
increase the demand for medical tourism which is consistent 
with the literature [3], [23]-[25]. Patients thus choose to 
travel to another country for medical procedure which could 
be private in nature such as cosmetic surgery, gender 
selection, drug rehabilitation treatment, gender change, for 
protecting their confidentiality and privacy of treatment, 
along with the opportunity to travel. Medical tourism 
service providers, hospital and medical tour operators, and 
hotels are prompted from the business sustainability point of 
view to protect and guarantee patient privacy and 
confidentiality. This involves privacy regarding medical 
treatment, reports, travel and accommodation plans and 
having an international patient privacy policy to build 
confidence of the patient in their service provision. Likewise 
this might include issues related to sensitivity to cultural 
differences. For example International Halal Integrity 
Alliance, (Malaysia) and Islamic Chamber of Commerce 
and Industry (Kingdom of Saudi Arabia) has certified the 
Global Health City in Chennai, India in June 2012, which 
provides ‘halal friendly’ medical tourism services [34].   
Given the globalisation of healthcare where the world is 
soon to become our hospital catering to complex surgical 
procedures due to the low costs, privacy, short waiting 
period, there is a need for developing sustainable GMTS 
supply chain to provide first world quality of  medical care. 
 












25,000 8,500 20,000 13,500 24,000 
Angioplasty 57,000 13,000 8,500 16,000 7,500 7,000 
Heart valve 
replacement 
170,00 30,000 1,200 30,000 13,500 22,000 
Hip 
replacement 
50,000 12,500 8,000 13, 125 11,100 14,000 
Knee 
replacement 





1,000 700 910 2,900 3,000 
Breast 
Implants 
10,000 3,500 4,500 8,000 5,400 3,700 
Source:  [33] American Medical Tourism Association (2009 prices)  
Note: Prices do not include the cost of airfares, food and accommodation in 
the destination country and hospitals.   
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